Allucent

Gold Sponsor

Allucent is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. We’re a global provider of comprehensive drug development solutions, including Clinical Development, Clinical Pharmacology, Regulatory Strategy and Drug Safety & Pharmacovigilance across a variety of therapeutic areas.

As a rare disease CRO Allucent has more than 30 years of expertise successfully navigating the unique challenges of rare and orphan disease clinical trials including ethical considerations in protocol design, small sample sizes, pharmacokinetic sampling limitations, the need for standardized subjective endpoints, vulnerability of the patient population, and constantly evolving regulatory requirements. Our individualized partnership approach provides experience-driven insights and expertise to assist clients in successfully navigating the complexities of delivering novel treatments to patients with rare and ultra-rare diseases.

Visit our website for further information, www.allucent.com

website